Form 4: Danaher Director Boosts Equity Holdings via Deferred Plan

Danaher Corporation Director Elias A. Zerhouni acquired 200.506 phantom shares through a deferred compensation plan on January 30, 2026.

Summary

• Director Elias A. Zerhouni acquired 200.506 phantom shares of Danaher Corporation common stock.
• The acquisition occurred on January 30, 2026, with the phantom shares valued at the closing price of $218.89 per share of Danaher common stock on that date.
• These phantom shares were obtained under the Non-Employee Directors Deferred Compensation Plan, where cash director fees are converted into notional shares.
• Following this transaction, Zerhouni beneficially owns a total of 18,212.564 phantom shares.
• The phantom shares are fully vested and will convert into shares of Danaher common stock on a one-for-one basis upon distribution.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director increasing their beneficial ownership, even through a deferred compensation plan, suggests continued confidence in the company's future performance and aligns their interests with shareholders.

Positives

• Director Elias A. Zerhouni increased his beneficial ownership in Danaher Corporation by acquiring 200.506 phantom shares, indicating continued alignment with shareholder interests.
• The acquisition through a deferred compensation plan suggests a long-term commitment to the company's performance.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the nature of the deferred compensation plan, which implies future conversion of phantom shares to common stock upon distribution.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions through deferred compensation plans, often signal management's confidence in the company's long-term prospects. This type of transaction is a common mechanism for non-employee directors to align their interests with shareholders without direct open market purchases.

Comparison to Industry Standards

• StockSavvy.ai observes that deferred compensation plans for non-employee directors, where fees are converted into equity-linked instruments like phantom shares, are a standard practice across many industries, including the healthcare and life sciences sector where Danaher operates.
• This aligns director incentives with long-term shareholder value, similar to practices at peers like Thermo Fisher Scientific (TMO) or Abbott Laboratories (ABT), which also utilize equity-based compensation for their non-executive directors.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased equity-linked ownership.

Next Steps

• The phantom shares will convert into shares of Danaher common stock on a one-for-one basis upon distribution.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of phantom shares by a director through a deferred compensation plan. While it indicates continued alignment of interests, it is not a significant market-moving event on its own to warrant a change from a 'hold' position. Investors should consider broader company fundamentals and market conditions.

Keywords

Danaher, DHR, SEC Form 4, Insider Transaction, Phantom Shares, Deferred Compensation, Director Ownership, Elias Zerhouni